Investors Urged to Act by Faruqi & Faruqi as Deadline Approaches for uniQure Securities Class Action

Legal Alert for uniQure Investors

As the securities class action deadline looms for investors in uniQure N.V. (NASDAQ: QURE), major national law firm Faruqi & Faruqi, LLP, is urging stakeholders to take action. Investors who experienced financial losses due to alleged misleading information provided by the company may be eligible to participate in a legal case against it, with a cutoff date of April 13, 2026, to assert their rights as lead plaintiffs.

Background and Allegations

Faruqi & Faruqi is currently investigating claims regarding potential violations of federal securities laws by uniQure. The firm cites a number of misleading statements made by the company's executives during the period from September 24, 2025, to October 31, 2025. Notably, these assertions concerned the approval status of clinical trial data intended for a Biologics License Application (BLA) submission.

It was revealed in a November 2025 disclosure that the U.S. Food and Drug Administration (FDA) no longer accepted certain clinical data from uniQure’s Phase I/II AMT-130 studies, raising doubts about the company’s plans for rapid approval. As a result, the company's stock price plummeted by over 49%, a significant loss for many investors.

Responsibilities of Potential Lead Plaintiffs

In a class action, the court appoints a lead plaintiff to oversee and manage the lawsuit for all affected investors. This lead plaintiff's primary responsibility is to guide the legal proceedings and advocate for the rights and interests of the entire class. Current shareholders of uniQure can either opt to take on this role or remain as passive members of the class, with none of these choices affecting their ability to recover in the case.

How to Take Action

Faruqi & Faruqi has emphasized that individuals with pertinent information about uniQure’s business practices, including whistleblowers and former employees, can assist the firm in its ongoing investigation. Investors wishing to learn more about their rights and potential actions should visit the law firm’s dedicated webpage or directly reach out to Partner Josh Wilson via the provided contact methods.

With the deadline approaching, it’s crucial for affected investors to understand their positions clearly and take action promptly if they want to pursue claims related to their losses in uniQure.

For further information, please refer to Faruqi & Faruqi’s website where you can find resources pertinent to this class action and instructions on how to proceed.

Conclusion

As the April 13 deadline draws near, careful consideration of the details surrounding the uniQure case and actions by impacted investors may provide a path to recovery. Engaging with legal professionals who specialize in securities law can offer invaluable guidance in these turbulent circumstances.